For Prelims: Biotechnology, Monoclonal Antibodies, Gene Therapy, Industrial Development Authority (UPCIDA)
For Mains: Decentralised industrialisation, Biotechnology manufacturing, Skill development and incubation, Regional employment, Make in India
Source:
Hindustan
5 facts for one-day exams
SSC, railway, police and teaching exams ask direct questions like these.
- Uttar Pradesh is developing a 951.79-acre industrial area in Pilibhit.
- A 200-acre Bio-Pharma Park is part of this industrial area.
- The park will manufacture vaccines, insulin, gene therapies, and monoclonal antibodies.
- The nodal agency for the project is Uttar Pradesh State Industrial Development Authority (UPCIDA).
- The industrial area is located in Bhara Pachpeda, Tehsil Amaria, Pilibhit.
Why in the news?
The Uttar Pradesh government, through UP Industrial Development Authority (UPCIDA), is developing a 951.79-acre industrial area in Bhara Pachpeda, Pilibhit, with a dedicated 200-acre Bio-Pharma Park. The park aims to boost biotechnology-based manufacturing of vaccines, insulin, gene therapies, and monoclonal antibodies, creating a new industrial ecosystem and employment in the Terai region.
Summary
- UPCIDA is developing a 951.79-acre industrial area in Bhara Pachpeda, Pilibhit, including a 200-acre Bio-Pharma Park for advanced biological medicines.
- The Bio-Pharma Park will focus on manufacturing vaccines, insulin, gene therapies, and monoclonal antibodies, leveraging Pilibhit's favourable climate and proximity to Nepal.
- The project includes plans for a biotechnology institute, skill development wing, and incubation centre to build human capital and promote startups.
Background
Uttar Pradesh has been focusing on decentralising industrial development beyond major cities like Noida, Lucknow, and Kanpur. The Pilibhit project aligns with Chief Minister Yogi Adityanath's vision to create regional investment and employment opportunities, especially in the underdeveloped Terai region. The state is also promoting the pharma and biotech sectors as part of its industrial policy.
Key Analysis and Impact
The Bio-Pharma Park will produce high-value biological medicines critical for modern healthcare, reducing import dependence and boosting domestic manufacturing under the 'Make in India' initiative. Pilibhit's climate is suitable for bio-formulation activities, and its proximity to the Nepal border offers export potential. The integrated skill development and incubation wing will create a skilled workforce, fostering innovation and startups in biotechnology.
Way Forward
The project is in the early stages with 14 industrial plots already available for allotment. Successful implementation could attract major pharma companies, generate thousands of jobs, and establish Pilibhit as a biotech hub in North India. The state government may need to ensure infrastructure connectivity, raw material supply chains, and regulatory clearances to realise the full potential.
Uttar Pradesh connection
Matters for these Uttar Pradesh exams:UPPSCUPPSC RO/AROUPSSSC PET
Background GK
Textbook concepts you need to understand this news
- Biotechnology
- The use of living systems and organisms to develop or make products, especially in medicine and agriculture.
- Monoclonal Antibodies
- Laboratory-made molecules that can mimic the immune system's ability to fight off harmful pathogens such as viruses.
- Gene Therapy
- A technique that modifies a person's genes to treat or cure disease, often by introducing a corrected copy of a gene.
- Industrial Development Authority (UPCIDA)
- A state government agency responsible for planning, promoting, and developing industrial areas and infrastructure in Uttar Pradesh.
Facts to remember
Tap a card to see the answer. Try to recall it first.
How exams will ask this
- Data: 200 acres for Bio-Pharma Park; total industrial area 951.79 acres in Bhara Pachpeda, Pilibhit
- Nodal Body: Uttar Pradesh State Industrial Development Authority (UPCIDA)
Common mistake:
Students may confuse the total industrial area (951.79 acres) with the Bio-Pharma Park area (200 acres), or swap the location (e.g., Pilibhit with another UP district like Bareilly or Lucknow).
Write these in mains answers
- Decentralised industrialisation, Biotechnology manufacturing, Skill development and incubation, Regional employment, Make in India
Stuck? Get it in one tap
The Uttar Pradesh government is building a large industrial area in Pilibhit, which includes a special Bio-Pharma Park for making advanced medicines like vaccines and insulin. A bio-pharma park is a dedicated zone where companies produce biological drugs using living cells, similar to how a tech park focuses on software companies. This project aims to create jobs and boost manufacturing in the region.
- Economy: Industrial policy and infrastructure
- Geography: Industrial regions of India
Related concepts: Biotechnology, Monoclonal Antibodies, Gene Therapy, Industrial Development Authority (UPCIDA)
Practice questions
Pick an answer, then read the explanation.
- Q1Hard
Consider the following statements regarding the Pilibhit Bio-Pharma Park:
- 1. The Bio-Pharma Park will cover 200 acres within a 951.79-acre industrial area.
- 2. The Uttar Pradesh State Industrial Development Authority (UPCIDA) is the nodal agency for the project.
- 3. The Pilibhit Bio-Pharma Park is located in Tehsil Amaria, Uttarakhand.
Which of the statements given above is/are correct?
Explanation: 1. True: The park covers 200 acres within a 951.79-acre industrial area. 2. True: UPCIDA is the nodal agency. 3. False: Tehsil Amaria is in Pilibhit, Uttar Pradesh.
- Q2Medium
How much land has been allocated for the Bio-Pharma Park in Pilibhit?
Explanation: 200 acres of land has been identified for the Bio-Pharma Park within the 951.79-acre industrial area. 575.79 acres is for industrial plots, and 109.23 acres is for green area.
- Q3Medium
What is the primary objective of establishing the Bio-Pharma Park in Pilibhit?
Explanation: The park aims to promote biotechnology-based manufacturing of advanced medicines and create local employment through skill development.
Frequently asked questions
1. Where is the new Bio-Pharma Park being developed in Uttar Pradesh?
The Bio-Pharma Park is being developed on 200 acres in Bhara Pachpeda, Tehsil Amaria, Pilibhit district, Uttar Pradesh.
2. What products will be manufactured at the Pilibhit Bio-Pharma Park?
The park will focus on manufacturing vaccines, insulin, gene therapies, and monoclonal antibodies.
3. Which agency is developing the Pilibhit industrial area?
The Uttar Pradesh State Industrial Development Authority (UPCIDA) is developing the 951.79-acre industrial area.
4. How much total land is being developed for the industrial area in Pilibhit?
A total of 951.79 acres is being developed, which includes industrial plots, common facilities, green areas, and road networks.
All sources
Original3 November 2026 · Read story

